The federal government has moved to stop any further risk of contamination at a Baltimore contract vaccine manufacturer where 15 million potential doses of Johnson & Johnson vaccine were spoiled ...

AstraZeneca and Johnson & Johnson have restarted their late-stage trials after finding that serious illnesses in a few volunteers appeared not to be related to the vaccines. By Katherine J.

"The AstraZeneca and Johnson & Johnson vaccines are made in a similar way," said Dr. William Schaffner, an infectious disease physician at Vanderbilt University with expertise in preventive ...

Confusion over AstraZeneca’s vaccine threatens to hurt the E.U. campaign just as it gathers momentum. And on Tuesday, Johnson & Johnson said it was pausing the rollout of its shot on the continent.

When scientists concluded that the AstraZeneca and Johnson & Johnson vaccines were associated with extremely rare blood clots, they had only the beginnings of a mystery. What in the vaccine was ...

Blood clots reported in recipients of the Johnson & Johnson vaccine are “similar” to the adverse reaction linked to AstraZeneca’s shot in Europe, a top health official said Wednesday.

South Africa has offered its stock of Oxford-AstraZeneca Covid-19 vaccines to the African Union, a senior health official said, as the country pivots to using shots developed by Johnson & Johnson ...

and Johnson & Johnson wasn't one of them! That's right -- they think these 10 stocks are even better buys. Keith Speights: South Africa just put AstraZeneca's COVID-19 vaccine on hold in the country.

Plus, Johnson & Johnson will spend $55 billion ... in investment compared to the previous four years. And finally, AstraZeneca will invest $2.5 billion in a new research center in Beijing, in ...